Tokio Marine Asset Management Co. Ltd. Purchases 559 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Tokio Marine Asset Management Co. Ltd. lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.5% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 13,119 shares of the company’s stock after acquiring an additional 559 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in GE HealthCare Technologies were worth $1,026,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in GEHC. LGT Financial Advisors LLC raised its position in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares during the period. Ashton Thomas Securities LLC purchased a new position in shares of GE HealthCare Technologies during the third quarter valued at about $26,000. Capital Performance Advisors LLP purchased a new position in shares of GE HealthCare Technologies during the third quarter valued at about $26,000. Darwin Wealth Management LLC purchased a new position in shares of GE HealthCare Technologies during the third quarter valued at about $31,000. Finally, Continuum Advisory LLC increased its position in shares of GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after buying an additional 168 shares during the period. 82.06% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO Roland Rott sold 3,577 shares of the company’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.27% of the stock is owned by company insiders.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $87.51 on Tuesday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The firm has a fifty day moving average price of $82.97 and a 200 day moving average price of $85.09. GE HealthCare Technologies Inc. has a fifty-two week low of $72.61 and a fifty-two week high of $94.55. The firm has a market cap of $39.98 billion, a price-to-earnings ratio of 24.04, a P/E/G ratio of 2.92 and a beta of 1.14.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. GE HealthCare Technologies’s dividend payout ratio is currently 3.85%.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.